Hydrochloric Acid → HCID 178480925, 화합물

HRID 1852547노트

반응식

HRID 1852547 반응식
Cl.C(OC(=O)[NH:8][C@H:9]1[CH2:14][CH2:13][C@H:12]([NH:15][C:16](=[O:25])[CH2:17][N:18]2[CH2:23][CH2:22][N:21]([CH3:24])[CH2:20][CH2:19]2)[CH2:11][CH2:10]1)(C)(C)C.CCOCC>CO>[NH2:8][C@H:9]1[CH2:10][CH2:11][C@H:12]([NH:15][C:16](=[O:25])[CH2:17][N:18]2[CH2:19][CH2:20][N:21]([CH3:24])[CH2:22][CH2:23]2)[CH2:13][CH2:14]1

참가 물질

5

반응물 3

HCID 313Hydrochloric AcidHCID 3283Diethyl EtherHCID 178480926HCID 178480926, 화합물

생성물 1

HCID 178480925HCID 178480925, 화합물

시약·촉매·용매 1

HCID 887Methanol용매

실험 절차

An aqueous solution of HCl (2 M, 15 mL) was added to a solution of trans-{4-[2-(4-methyl-piperazin-1-yl)-acetylamino]-cyclohexyl}-carbamic acid tert-butyl ester (199 mg, 0.56 mmol) in MeOH (15 mL) at RT, and the resulting mixture was stirred overnight. The reaction mixture was concentrated under reduced pressure to give a solid residue. Et2O was added to this material, and the resulting suspension was sonicated. The ether phase was decanted away, leaving a powdery brown solid which was purified by preparative TLC. The resulting oil was dissolved in the minimum quantity of MeOH, and Et2O was added. A solid precipitated; the liquid phase was decanted away to give, after drying, 75 mg of trans-N-(4-amino-cyclohexyl)-2-(4-methyl-piperazin-1-yl)-acetamide as a fine powder.

후처리

  1. concentrationThe reaction mixture was concentrated under reduced pressure
  2. customto give a solid residue
  3. customthe resulting suspension was sonicated
  4. customThe ether phase was decanted away
  5. customleaving a powdery brown solid which
  6. customwas purified by preparative TLC
  7. dissolutionThe resulting oil was dissolved in the minimum quantity of MeOH, and Et2O
  8. additionwas added
  9. customA solid precipitated
  10. customthe liquid phase was decanted away
  11. customto give
  12. customafter drying

출처 및 근거

ORD 기록
ord-9447c1ba99b44f1c87d452cbae8b3f1d
출처 데이터셋
uspto-grants-2015_02
특허 번호
US08962622B2

반응 노트

불러오는 중…